Company is sending more people to supervise manufacturing at the Baltimore plant after a human error caused the problem
Johnson & Johnson said on Wednesday it had found a problem with a batch of drug substance for its Covid-19 vaccine, which did not meet quality standards at Emergent Biosolutions’ production site in Baltimore, Maryland.
The issue was identified and addressed with Emergent and shared with the US Food and Drug Administration, J&J said, adding it was sending more people to supervise manufacturing at the plant.
Continue reading...from World news | The Guardian https://ift.tt/3fs5ulz
No comments:
Post a Comment